MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 49 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,089 | -47.5% | 86,839 | -51.8% | 0.00% | – |
| Q2 2023 | $513,003 | -28.9% | 179,987 | -1.8% | 0.00% | – |
| Q1 2023 | $721,806 | +97573.3% | 183,244 | -1.9% | 0.00% | – |
| Q4 2022 | $739 | -99.9% | 186,725 | +154.8% | 0.00% | – |
| Q3 2022 | $673,000 | +50.2% | 73,274 | -2.7% | 0.00% | – |
| Q2 2022 | $448,000 | +12.8% | 75,346 | +22.0% | 0.00% | – |
| Q1 2022 | $397,000 | +15.1% | 61,743 | +17.4% | 0.00% | – |
| Q4 2021 | $345,000 | +32.7% | 52,578 | +15.5% | 0.00% | – |
| Q3 2021 | $260,000 | 0.0% | 45,517 | -3.6% | 0.00% | – |
| Q2 2021 | $260,000 | +17.1% | 47,200 | +23.2% | 0.00% | – |
| Q1 2021 | $222,000 | +48.0% | 38,316 | +71.4% | 0.00% | – |
| Q4 2020 | $150,000 | – | 22,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alta Fundamental Advisers LLC | 1,176,189 | $3,646,186 | 1.74% |
| Bleichroeder LP | 1,326,085 | $4,110,864 | 1.01% |
| BML Capital Management, LLC | 272,500 | $844,750 | 0.78% |
| VR Adviser, LLC | 2,208,812 | $6,847,317 | 0.72% |
| Lion Point Capital, LP | 450,207 | $1,395,642 | 0.62% |
| PVG ASSET MANAGEMENT CORP | 15,405 | $47,755 | 0.32% |
| Affinity Asset Advisors, LLC | 335,068 | $1,038,711 | 0.29% |
| RTW INVESTMENTS, LP | 3,256,102 | $10,093,916 | 0.21% |
| Ikarian Capital, LLC | 462,828 | $1,434,767 | 0.17% |
| Boxer Capital, LLC | 309,007 | $957,922 | 0.05% |